The fact
Developed to limit symptom worsening, it targets inflammatory mechanisms in the airways.
Its cost and accessibility remain major challenges for patients and healthcare systems.
Click the link to read an article on the topic:
Developed to limit symptom worsening, it targets inflammatory mechanisms in the airways.
Its cost and accessibility remain major challenges for patients and healthcare systems.